In his Jan 17 note, Ong says that the sector has been in the “doldrums” for almost two years since profits peaked in FY2022 along with the gradual cessation of Covid-19 services.
Maybank Singapore analyst Eric Ong is keeping his “neutral” call on the Singapore healthcare sector, while looking out for signs of a “turnaround” in 2025.
The analyst highlights three Singapore healthcare listed stocks, Raffles Medical, Thomson Medical and Q&M Dental. He has a “hold” call for both Raffles Medical and Q&M Dental with a target price of $1 and 31 cents respectively, and a “buy” call for Thomson Medical with a target price of 6 cents.
